VOLITIONRX LTD

NYSE:VNRX

In Vitro & In Vivo Diagnostic Substances·HENDERSON, NV

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q/A	Q2 2025	6/30/25	8/15/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

34 shown

Filed	Period
11/13/25	Q4 FY2025	→
10/14/25	Q3 FY2025	→
8/14/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
↓

News (8-K)

46 shown

Filed	Type	Description
2/20/26	Other	Unregistered Sales of Equity Securities	→
2/9/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
1/8/26	Agreement	Entry into a Material Definitive Agreement	→
12/11/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/13/25	Agreement	Entry into a Material Definitive Agreement	→
11/10/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/9/26	S-3	S-3	→
10/14/25	424B5	PROSPECTUS SUPPLEMENT	→
10/9/25	424B5	PROSPECTUS SUPPLEMENT	→
8/14/25	424B5	PROSPECTUS SUPPLEMENT	→
8/4/25	424B5	424B5	→
7/3/25	S-3	S-3	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

Mar 3, 2026

0001477932-26-001147FORM 4

Mar 1, 2026

6.1 KB

Mar 3, 2026

0001477932-26-001146FORM 4

Mar 1, 2026

6.6 KB

Mar 3, 2026

0001477932-26-001145FORM 4

Mar 1, 2026

5.0 KB

Feb 27, 2026

0001477932-26-001105FORM 4

Feb 26, 2026

7.2 KB

Feb 27, 2026

0001477932-26-001104FORM 4

Feb 26, 2026

5.3 KB

Feb 27, 2026

0001477932-26-001103FORM 4

Feb 26, 2026

7.1 KB

Feb 27, 2026

0001477932-26-001102FORM 4

Feb 26, 2026

6.1 KB

Feb 27, 2026

0001477932-26-001101FORM 4

Feb 26, 2026

5.4 KB

Feb 27, 2026

0001477932-26-001100FORM 4

Feb 26, 2026

6.4 KB

Feb 27, 2026

0001477932-26-001099FORM 4

Feb 26, 2026

5.4 KB

Feb 27, 2026

0001477932-26-001098FORM 4

Feb 26, 2026

6.0 KB

Feb 27, 2026

0001477932-26-001097FORM 4

Feb 26, 2026

6.0 KB

Feb 27, 2026

0001477932-26-001096FORM 4

Feb 26, 2026

7.1 KB

Feb 27, 2026

0001477932-26-001095FORM 4

Feb 26, 2026

10.1 KB

8-K

Feb 20, 2026

0001477932-26-000955FORM 8-K

Feb 17, 2026

137.1 KB

EFFECT

Feb 19, 2026

9999999995-26-000634

—

1.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001228

—

10.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001493152-26-007137

—

8.2 KB

DEF 14A

Feb 11, 2026

0001477932-26-000757DEF 14A

Feb 10, 2026

1.0 MB

8-K

Feb 9, 2026

0001477932-26-000714FORM 8-K

Feb 6, 2026

159.3 KB

S-3

Feb 9, 2026

0001477932-26-000711FORM S-3

—

425.5 KB

Feb 3, 2026

0001477932-26-000607FORM 4

Feb 1, 2026

6.9 KB

Feb 3, 2026

0001477932-26-000606FORM 4

Feb 1, 2026

6.1 KB

Feb 3, 2026

0001477932-26-000605FORM 4

Feb 1, 2026

5.0 KB

D/A

Jan 28, 2026

0001477932-26-000461

—

17.8 KB

25 filings shown

VOLITIONRX LTD

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/11/26	DEF 14A	DEF 14A	→
1/26/26	PRE 14A	PRE 14A	→
4/29/25	DEF 14A	DEF 14A	→
4/4/25	PRE 14A	PRE 14A	→
5/13/24	DEF 14A	DEF 14A	→
4/26/24	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
3/3/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
2/27/26	4	4	→
2/27/26	4	4	→
2/27/26	4	4	→
↓

Filed	Form	Description
2/19/26	EFFECT	EFFECT	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/28/26	D/A	D/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓